Dec 20, 2019
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $0.26 to $0.03.
The split itself did not change the total investment value.
Protalix BioTherapeutics, Inc. (PLX) trades on the New York Stock Exchange Arca in the Biotechnology industry.
Protalix BioTherapeutics, Inc. company overviewThe latest split shown was on December 20, 2019. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
This history records 2 reverse splits between January 3, 2007 and December 20, 2019.